Last reviewed · How we verify
NCT04430647
Phaco-UCP Versus Phaco Alone for OAG and Cataract
NA trial testing combined phacoemulsification and ultrasound ciliary plasty (Phaco-UCP) in Cataract in 61 participants. Completed in 30 January 2020.
1 September 2019
Quick facts
| Lead sponsor | Ameera Gamal Abdelhameed |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 61 |
| Start date | 1 March 2018 |
| Primary completion | 1 September 2019 |
| Estimated completion | 30 January 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- combined phacoemulsification and ultrasound ciliary plasty (Phaco-UCP)
- Phacoemulsification alone
Conditions studied
- Cataract — all drugs for Cataract →
- Glaucoma, Open-Angle — all drugs for Glaucoma, Open-Angle →
Sponsor
Ameera Gamal Abdelhameed — full company profile →
Who can join
Adults 40 to 80, any sex, with Cataract or Glaucoma, Open-Angle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was carried out to evaluate the safety and efficacy of combined phacoemulsification and Ultrasound ciliary plasty (Phaco-UCP) as a first-line surgical treatment of coexisting cataract and op /en angle glaucoma compared to phacoemulsification alone. To our knowledge, this is the first report of results of combined Phaco-UCP
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Phaco-UCP; combined phacoemulsification and ultrasound ciliary plasty versus phacoemulsification alone for management of coexisting cataract and open angle glaucoma: a randomized clinical trial.
Torky MA, Alzafiri YA, Abdelhameed AG, Awad EA. · · 2021 · cited 9× · PMID 33478426 · DOI 10.1186/s12886-021-01818-5
Verify or expand the search:
- PubMed search for NCT04430647
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Ameera Gamal Abdelhameed trials
Trials by the same sponsor.
- NCT04539106 — Intravitreal Ranibizumab in Recurrent ROP · completed
- NCT04537065 — Long Term Outcome of Intravitreal Ranibizumab for ROP · completed
- NCT04433936 — Corneal Tomographic Parameters in TGD · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04430647 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ameera Gamal Abdelhameed
- Last refreshed: 12 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04430647.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing